Joint pain is not a common class-wide side effect of GLP-1 medications, though musculoskeletal symptoms appear in certain product summaries
PlexusDx works with your provider to ensure your refill aligns with your dosing plan
At the core of the program are GLP-1 medications like semaglutide ( Ozempic , Wegovy ) and tirzepatide (Mounjaro) powerful peptides that support weight loss by decreasing appetite, regulating blood sugar, and enhancing metabolic function
This results in increased use of health care resources, including the need for hospitalization and the use of nonconventional medication [4]
Initial assessment should include a detailed history characterizing the joint symptoms: onset relative to medication initiation, location and pattern of joint involvement, severity and functional impact, aggravating and relieving factors, and any associated symptoms such as swelling, redness, or morning stiffness